EIM
XTNT icon

Essex Investment Management’s Xtant Medical Holdings XTNT Stock Holding History

Essex Investment Management’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-905
Closed -$49K – 358
2014
Q3 		$49K Buy
+905
New +$60.1K 0.01% 349

Other funds holding XTNT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
OA
Outfitter Advisors Mclean, Virginia $221M AUM 13.61% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
RCM
Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Essex Investment Management's XTNT Position: Q4 2014 in Review

Essex Investment Management sold out of Xtant Medical Holdings (XTNT) in Q4 2014, closing a stake of 905 shares — an estimated $49K sold.

Essex Investment Management first reported a position in XTNT in Q3 2014 and held it in 1 quarter. The position peaked at $49K in Q3 2014. 17 funds tracked by Wall St. Rank hold XTNT as of Q4 2014.

  • Essex Investment Management reported no remaining Xtant Medical Holdings position as of Q4 2014 after selling out during the quarter.
  • Essex Investment Management sold 905 Xtant Medical Holdings shares in Q4 2014, an estimated $49K.
  • Essex Investment Management first reported a position in Xtant Medical Holdings in Q3 2014 and held it in 1 quarter.
  • Essex Investment Management's Xtant Medical Holdings position peaked at $49K in Q3 2014.
  • 17 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q4 2014.

Based on Essex Investment Management's 13F filing for Q4 2014, filed 27 Jan 2015.